These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25963090)

  • 1. Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials.
    Kerbel RS; Grothey A
    Nat Rev Clin Oncol; 2015 Jun; 12(6):313-4. PubMed ID: 25963090
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
    Bocci G; Kerbel RS
    Nat Rev Clin Oncol; 2016 Nov; 13(11):659-673. PubMed ID: 27184418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the pooled analysis of the north central cancer treatment group phase III trials N9741 and N9841 biased?
    Mandalà M; Grosso F
    J Clin Oncol; 2012 May; 30(15):1894-5; author reply 1895. PubMed ID: 22473158
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of oral chemotherapy in colorectal cancer.
    Donehower RC
    Oncology (Williston Park); 2000 Nov; 14(11A):243-5. PubMed ID: 11195416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting.
    Grothey A
    Clin Adv Hematol Oncol; 2012 Jul; 10(7 Suppl 9):1-24. PubMed ID: 22895157
    [No Abstract]   [Full Text] [Related]  

  • 7. Regarding 'Treatment of colorectal cancer with and without bevacizumab: a phase III study'.
    Kabbinavar F; Kozloff M
    Oncology; 2011; 80(1-2):135-7; author reply 140-1. PubMed ID: 21677459
    [No Abstract]   [Full Text] [Related]  

  • 8. TAS-102 in metastatic colorectal cancer.
    Burki TK
    Lancet Oncol; 2018 Jan; 19(1):e18. PubMed ID: 29249306
    [No Abstract]   [Full Text] [Related]  

  • 9. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer.
    Maung K
    Clin Colorectal Cancer; 2003 Nov; 3(3):150-3. PubMed ID: 14706173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
    Krieger G
    Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regional adjuvant chemotherapy in colorectal cancer].
    Shparyk IaV; Bilyns'kyĭ BT
    Klin Khir; 1995; (9-10):41-5. PubMed ID: 8697216
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecan.
    Pazdur R
    J Gastroenterol; 2000; 35 Suppl 12():131. PubMed ID: 10779234
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimum chemotherapy for metastatic colorectal cancer.
    Bendell J
    Lancet; 2006 Dec; 368(9552):2039-41. PubMed ID: 17161715
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy for advanced colorectal cancer.
    Mason M; Johnson P; Rudd R;
    Br J Cancer; 2003 Apr; 88(7):1152-3; author reply 1153-5. PubMed ID: 12671718
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastrointestinal cancer: FOLFOXIRI-improving outcomes of metastatic colorectal cancer.
    Errico A
    Nat Rev Clin Oncol; 2014 Dec; 11(12):684. PubMed ID: 25384949
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase III aflibercept-chemotherapy combination trial shows benefit in previously treated metastatic colorectal cancer patients.
    Oncology (Williston Park); 2011 Nov; 25(12):1213. PubMed ID: 22229217
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of inoperable colorectal cancer].
    Herrmann R
    Wien Med Wochenschr; 1988 Jul; 138(13):310-3. PubMed ID: 3055690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
    Porschen R
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on 'Treatment of colorectal cancer with and without bevacizumab: a phase III study'.
    Boisen MK; Johansen JS; Larsen O; Jensen BV
    Oncology; 2011; 80(1-2):138-9. PubMed ID: 21677460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.